Fmoc-L-His(1-Me)-OH

Fmoc-L-His(1-Me)-OH is an Fmoc-protected L-histidine derivative bearing a methyl substituent at the N1 position of the imidazole ring, preserving the amino acid stereocenter while introducing a defined, N-methylated side-chain microenvironment. The structure contains an Fmoc carbamate on the alpha-amino group and a free carboxylic acid, enabling controlled peptide coupling at the C-terminus while maintaining orthogonality for downstream manipulations. The N1-methylated imidazole is less prone to protonation-state switching than unsubstituted histidine, which can influence hydrogen-bonding patterns and metal-binding behavior in peptide and biomolecule contexts. The compound functions as a chiral, protected amino acid building block with a reactivity profile compatible with standard peptide synthesis chemistries and as a chemically defined intermediate for histidine N-alkylation studies.

1. Peptide Synthesis

Fmoc-L-His(1-Me)-OH is used in peptide building block preparation where Fmoc protection supports stepwise solid-phase or solution-phase peptide coupling, and the free carboxylic acid participates in amide bond formation at the peptide C-terminus. The N1-methylated imidazole side chain provides a defined histidine mimic that can be incorporated to modulate imidazole protonation and metal-coordination geometry in peptide sequences. The Fmoc group enables orthogonal deprotection under base conditions, allowing sequential assembly of protected residues without exposing the side-chain functionality prematurely. Resulting N-methyl-histidine-containing peptides can serve as chemically controlled substrates, scaffolds, or reference analogs for studying sequence-dependent recognition and side-chain microenvironment effects in peptide science.

2. Protein Engineering

Fmoc-L-His(1-Me)-OH supports protein engineering workflows that rely on chemically synthesized peptides or semisynthetic proteins to probe the role of histidine side-chain chemistry in binding and catalysis. The preserved L-configuration at the alpha-carbon ensures stereochemical fidelity when incorporated into peptide segments that model protein active sites or interaction motifs. The N1-methylated imidazole can reduce accessibility of the ring nitrogen to protonation and can alter hydrogen-bond donor/acceptor balance, enabling structure-function mapping of histidine-derived interactions. Downstream, peptides containing this residue can be used as tools for designing and evaluating protein variants, receptor-binding segments, or enzyme-site mimics where precise side-chain electronic properties are required.

3. Bioconjugation Chemistry

Fmoc-L-His(1-Me)-OH is applicable to bioconjugation and chemical biology strategies that require defined amino acid side-chain behavior for controlled conjugate assembly. The Fmoc-protected amino acid format allows incorporation into peptides bearing functional handles, while the N-methylated imidazole can serve as a stable, chemically characterized recognition element in linker regions. The imidazole ring remains present for potential coordination or hydrogen-bonding interactions, but the N1 methylation can tune reactivity toward conditions that would otherwise lead to variable protonation or side reactions. Resulting N-methyl-histidine-containing conjugates can be employed as molecular probes, affinity handles, or scaffold components for downstream labeling and biomolecule modification workflows.

4. Chemical Biology Probes

Fmoc-L-His(1-Me)-OH enables chemical biology research that investigates histidine-dependent interactions using residue-level analogs with controlled imidazole substitution. The N1-methyl substitution creates a well-defined side-chain electronic and steric profile while retaining the canonical imidazole motif for interaction with neighboring residues or ligands. The protected amino acid form supports reliable incorporation into peptide probes, allowing researchers to compare analogs differing specifically at the imidazole N-substitution pattern. Downstream use includes generation of reference peptides for mapping binding modes, assessing metal-ion association tendencies, and supporting structure-activity relationship studies where histidine chemistry is a key variable.

5. Process Chemistry Intermediate

Fmoc-L-His(1-Me)-OH is suitable as a chiral intermediate in process chemistry intermediate preparation for manufacturing peptide building blocks and related protected amino acids. The compound's Fmoc carbamate and carboxylic acid functional groups provide clear handles for scalable protection/deprotection logic and for integration into automated peptide synthesis supply chains. The N1-methylated imidazole can improve batch-to-batch consistency of side-chain behavior by limiting protonation-state variability relative to unsubstituted histidine derivatives. Downstream, this stereochemically defined intermediate can be used to produce N-methyl-histidine-containing peptide reagents, analytical standards, and fine-chemical intermediates used across peptide manufacturing and applied synthetic chemistry.

1. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

3. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

4. Implications of ligand-receptor binding kinetics on GLP-1R signalling

5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis